Cefonicid
Systematic (IUPAC) name | |
---|---|
(6R,7R)-7-[(2R)-2-hydroxy-2-phenylacetyl)amino]-8-oxo- 3-{[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl}- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601206 |
Identifiers | |
CAS Number | 61270-58-4 |
ATC code | J01DC06 (WHO) |
PubChem | CID 43594 |
ChemSpider | 39734 |
UNII | 6532B86WFG |
KEGG | D07644 |
ChEBI | CHEBI:3491 |
ChEMBL | CHEMBL1601 |
Chemical data | |
Formula | C18H18N6O8S3 |
Molar mass | 542.569 g/mol |
| |
| |
(verify) |
Cefonicide (or cefonicid) is a cephalosporin antibiotic.[1]
It has a density of 1.92g/cm3.
Synthesis
Injectable semi-synthetic cephalosporin antibiotic related to cefamandole, q.v.
Cefonicid is synthesized conveniently by nucleophilic displacement of the 3-acetoxy moiety of 1 with the appropriately substituted tetrazole thiole 2. The mandelic acid amide C-7 side chain is reminiscent of cefamandole.
References
- ↑ Saltiel, E; Brogden, R. N. (1986). "Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use". Drugs 32 (3): 222–59. PMID 3530703.
- ↑ D. A. Berges, DE 2611270; idem, U.S. Patent 4,048,311 (1976, 1977 both to Smith Kline).
- ↑ U.S. Patent 4,093,723, U.S. Patent 4,159,373 (1978, 1979 both to Smith Kline).
See also
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.